Omar Gammoh, Mohammad Mansour, Suha Al Hababbeh, Wail Ennab, Alaa A A Aljabali, Murtaza M Tambuwala, Ammena Y Binsaleh, Sireen Abdul Rahim Shilbayeh
{"title":"约旦被诊断患有复发性缓解型多发性硬化症的妇女中的失眠和纤维肌痛样症状:患病率和相关性。","authors":"Omar Gammoh, Mohammad Mansour, Suha Al Hababbeh, Wail Ennab, Alaa A A Aljabali, Murtaza M Tambuwala, Ammena Y Binsaleh, Sireen Abdul Rahim Shilbayeh","doi":"10.1177/00912174241255420","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This study examined the prevalence and correlates of fibromyalgia and insomnia in a convenience sample of Women with Multiple Sclerosis (WMS).</p><p><strong>Methods: </strong>The study was cross-sectional in design and recruited a sample of 163 women with Relapsing-Remitting Multiple Sclerosis (RRMS). Fibromyalgia was assessed using the Patient Self-Report Survey (PSRS), which follows criteria outlined by the American College of Rheumatology. Insomnia was measured using the Arabic version of the Insomnia Severity Index (ISI-A).</p><p><strong>Results: </strong>The prevalence of fibromyalgia and insomnia was 28.2% (n = 46) and 46.3% (n = 76), respectively. Multivariate analyses were used to determine significant independent correlates. Fibromyalgia was associated with age above 40 years (OR = 2.29, 95% CI = 1.01-5.18, <i>P</i> = .04), high school education (OR = 3.69, 95% CI = 1.62-8.37, <i>P</i> = .002), and non-use of analgesics (OR = .02, 95% CI = .004-.21, <i>P</i> = .001). Insomnia symptoms were significantly associated only with age above 40 years (OR = 2.16, 95% CI = 1.16-4.04, <i>P</i> = .01).</p><p><strong>Conclusion: </strong>These findings highlight the need for increased attention by primary care physicians towards diagnosing and treating fibromyalgia and insomnia among women with RRMS in Jordan, particularly for older women.</p>","PeriodicalId":50294,"journal":{"name":"International Journal of Psychiatry in Medicine","volume":" ","pages":"131-142"},"PeriodicalIF":1.1000,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Insomnia and fibromyalgia-like symptoms among women diagnosed with relapsing remitting multiple sclerosis in Jordan: Prevalence and correlates.\",\"authors\":\"Omar Gammoh, Mohammad Mansour, Suha Al Hababbeh, Wail Ennab, Alaa A A Aljabali, Murtaza M Tambuwala, Ammena Y Binsaleh, Sireen Abdul Rahim Shilbayeh\",\"doi\":\"10.1177/00912174241255420\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>This study examined the prevalence and correlates of fibromyalgia and insomnia in a convenience sample of Women with Multiple Sclerosis (WMS).</p><p><strong>Methods: </strong>The study was cross-sectional in design and recruited a sample of 163 women with Relapsing-Remitting Multiple Sclerosis (RRMS). Fibromyalgia was assessed using the Patient Self-Report Survey (PSRS), which follows criteria outlined by the American College of Rheumatology. Insomnia was measured using the Arabic version of the Insomnia Severity Index (ISI-A).</p><p><strong>Results: </strong>The prevalence of fibromyalgia and insomnia was 28.2% (n = 46) and 46.3% (n = 76), respectively. Multivariate analyses were used to determine significant independent correlates. Fibromyalgia was associated with age above 40 years (OR = 2.29, 95% CI = 1.01-5.18, <i>P</i> = .04), high school education (OR = 3.69, 95% CI = 1.62-8.37, <i>P</i> = .002), and non-use of analgesics (OR = .02, 95% CI = .004-.21, <i>P</i> = .001). Insomnia symptoms were significantly associated only with age above 40 years (OR = 2.16, 95% CI = 1.16-4.04, <i>P</i> = .01).</p><p><strong>Conclusion: </strong>These findings highlight the need for increased attention by primary care physicians towards diagnosing and treating fibromyalgia and insomnia among women with RRMS in Jordan, particularly for older women.</p>\",\"PeriodicalId\":50294,\"journal\":{\"name\":\"International Journal of Psychiatry in Medicine\",\"volume\":\" \",\"pages\":\"131-142\"},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2025-03-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Psychiatry in Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/00912174241255420\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/5/21 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Psychiatry in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00912174241255420","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/5/21 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
摘要
研究目的本研究调查了纤维肌痛和失眠在多发性硬化症(WMS)女性患者样本中的患病率及其相关性:本研究采用横断面设计,招募了 163 名患有复发性-缓解性多发性硬化症(RRMS)的女性样本。根据美国风湿病学会(American College of Rheumatology)制定的标准,使用患者自述调查(PSRS)对纤维肌痛进行评估。失眠采用阿拉伯语版失眠严重程度指数(ISI-A)进行测量:纤维肌痛和失眠的患病率分别为 28.2%(n = 46)和 46.3%(n = 76)。多变量分析用于确定重要的独立相关因素。纤维肌痛与 40 岁以上(OR = 2.29,95% CI = 1.01-5.18,P = .04)、高中教育程度(OR = 3.69,95% CI = 1.62-8.37,P = .002)和不使用镇痛剂(OR = .02,95% CI = .004-.21,P = .001)有关。失眠症状仅与 40 岁以上有明显相关性(OR = 2.16,95% CI = 1.16-4.04,P = .01):这些发现突出表明,约旦的初级保健医生需要更加关注纤维肌痛和失眠症的诊断和治疗,尤其是老年女性 RRMS 患者。
Insomnia and fibromyalgia-like symptoms among women diagnosed with relapsing remitting multiple sclerosis in Jordan: Prevalence and correlates.
Objective: This study examined the prevalence and correlates of fibromyalgia and insomnia in a convenience sample of Women with Multiple Sclerosis (WMS).
Methods: The study was cross-sectional in design and recruited a sample of 163 women with Relapsing-Remitting Multiple Sclerosis (RRMS). Fibromyalgia was assessed using the Patient Self-Report Survey (PSRS), which follows criteria outlined by the American College of Rheumatology. Insomnia was measured using the Arabic version of the Insomnia Severity Index (ISI-A).
Results: The prevalence of fibromyalgia and insomnia was 28.2% (n = 46) and 46.3% (n = 76), respectively. Multivariate analyses were used to determine significant independent correlates. Fibromyalgia was associated with age above 40 years (OR = 2.29, 95% CI = 1.01-5.18, P = .04), high school education (OR = 3.69, 95% CI = 1.62-8.37, P = .002), and non-use of analgesics (OR = .02, 95% CI = .004-.21, P = .001). Insomnia symptoms were significantly associated only with age above 40 years (OR = 2.16, 95% CI = 1.16-4.04, P = .01).
Conclusion: These findings highlight the need for increased attention by primary care physicians towards diagnosing and treating fibromyalgia and insomnia among women with RRMS in Jordan, particularly for older women.
期刊介绍:
The International Journal of Psychiatry in Medicine (IJPM) bridges the gap between clinical psychiatry research and primary care clinical research. Providing a forum for addressing: The relevance of psychobiological, psychological, social, familial, religious, and cultural factors in the development and treatment of illness; the relationship of biomarkers to psychiatric symptoms and syndromes in primary care...